Diabetic aggravation of stroke and animal models

Ashish K. Rehni, Allen Liu, Miguel Perez-Pinzon, Kunjan R Dave

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Cerebral ischemia in diabetics results in severe brain damage. Different animal models of cerebral ischemia have been used to study the aggravation of ischemic brain damage in the diabetic condition. Since different disease conditions such as diabetes differently affect outcome following cerebral ischemia, the Stroke Therapy Academic Industry Roundtable (STAIR) guidelines recommends use of diseased animals for evaluating neuroprotective therapies targeted to reduce cerebral ischemic damage. The goal of this review is to discuss the technicalities and pros/cons of various animal models of cerebral ischemia currently being employed to study diabetes-related ischemic brain damage. The rational use of such animal systems in studying the disease condition may better help evaluate novel therapeutic approaches for diabetes related exacerbation of ischemic brain damage.

Original languageEnglish (US)
Pages (from-to)63-79
Number of pages17
JournalExperimental Neurology
Volume292
DOIs
StatePublished - Jun 1 2017

Fingerprint

Brain Ischemia
Animal Models
Stroke
Brain
Animal Diseases
Industry
Therapeutics
Guidelines

Keywords

  • Focal cerebral ischemia
  • Global cerebral ischemia
  • Hemorrhage
  • Preclinical models
  • Stroke
  • Translational research
  • White matter damage

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Diabetic aggravation of stroke and animal models. / Rehni, Ashish K.; Liu, Allen; Perez-Pinzon, Miguel; Dave, Kunjan R.

In: Experimental Neurology, Vol. 292, 01.06.2017, p. 63-79.

Research output: Contribution to journalReview article

@article{9f128b6c53774f6586b3ed54718113aa,
title = "Diabetic aggravation of stroke and animal models",
abstract = "Cerebral ischemia in diabetics results in severe brain damage. Different animal models of cerebral ischemia have been used to study the aggravation of ischemic brain damage in the diabetic condition. Since different disease conditions such as diabetes differently affect outcome following cerebral ischemia, the Stroke Therapy Academic Industry Roundtable (STAIR) guidelines recommends use of diseased animals for evaluating neuroprotective therapies targeted to reduce cerebral ischemic damage. The goal of this review is to discuss the technicalities and pros/cons of various animal models of cerebral ischemia currently being employed to study diabetes-related ischemic brain damage. The rational use of such animal systems in studying the disease condition may better help evaluate novel therapeutic approaches for diabetes related exacerbation of ischemic brain damage.",
keywords = "Focal cerebral ischemia, Global cerebral ischemia, Hemorrhage, Preclinical models, Stroke, Translational research, White matter damage",
author = "Rehni, {Ashish K.} and Allen Liu and Miguel Perez-Pinzon and Dave, {Kunjan R}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.expneurol.2017.03.004",
language = "English (US)",
volume = "292",
pages = "63--79",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Diabetic aggravation of stroke and animal models

AU - Rehni, Ashish K.

AU - Liu, Allen

AU - Perez-Pinzon, Miguel

AU - Dave, Kunjan R

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Cerebral ischemia in diabetics results in severe brain damage. Different animal models of cerebral ischemia have been used to study the aggravation of ischemic brain damage in the diabetic condition. Since different disease conditions such as diabetes differently affect outcome following cerebral ischemia, the Stroke Therapy Academic Industry Roundtable (STAIR) guidelines recommends use of diseased animals for evaluating neuroprotective therapies targeted to reduce cerebral ischemic damage. The goal of this review is to discuss the technicalities and pros/cons of various animal models of cerebral ischemia currently being employed to study diabetes-related ischemic brain damage. The rational use of such animal systems in studying the disease condition may better help evaluate novel therapeutic approaches for diabetes related exacerbation of ischemic brain damage.

AB - Cerebral ischemia in diabetics results in severe brain damage. Different animal models of cerebral ischemia have been used to study the aggravation of ischemic brain damage in the diabetic condition. Since different disease conditions such as diabetes differently affect outcome following cerebral ischemia, the Stroke Therapy Academic Industry Roundtable (STAIR) guidelines recommends use of diseased animals for evaluating neuroprotective therapies targeted to reduce cerebral ischemic damage. The goal of this review is to discuss the technicalities and pros/cons of various animal models of cerebral ischemia currently being employed to study diabetes-related ischemic brain damage. The rational use of such animal systems in studying the disease condition may better help evaluate novel therapeutic approaches for diabetes related exacerbation of ischemic brain damage.

KW - Focal cerebral ischemia

KW - Global cerebral ischemia

KW - Hemorrhage

KW - Preclinical models

KW - Stroke

KW - Translational research

KW - White matter damage

UR - http://www.scopus.com/inward/record.url?scp=85014886440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014886440&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2017.03.004

DO - 10.1016/j.expneurol.2017.03.004

M3 - Review article

C2 - 28274862

AN - SCOPUS:85014886440

VL - 292

SP - 63

EP - 79

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

ER -